Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT01940276
Title Abiraterone Race in Metastatic Castrate-resistant Prostate Cancer
Recruitment Completed
Gender male
Phase Phase II
Variant Requirements No
Sponsors Duke University
Indications

prostate adenocarcinoma

Therapies

Abiraterone + Prednisone

Age Groups: adult
Covered Countries USA


No variant requirements are available.